This presentation should be considered forward-looking and is subject to various risk factors and uncertainties. For more information on those risk factors, please refer to Gentiva's various filings with the Securities and Exchange Commission (SEC). This presentation also is produced in compliance with the SEC's Regulation FD, which provides guidelines on all disclosures by publicly-traded companies.

The reader should not place undue reliance on forward-looking statements, which speak only as of the date indicated in this presentation. The Company is not obligated to publicly release any revisions to forward-looking statements to reflect unforeseen or other events after such date.